← Russell 3000 cross-section

CME CME GROUP INC.

Trailing twelve months to 2026-06-30 · as filed 2026-07-24, not restated
Financials

Scale

Market cap
$99.7bn
Revenue TTM
$6.8bn
Net income TTM
$4.3bn
Free cash flow
$4.2bn
Composite score
44.3
Sector rank
#121

Valuation

P / E
23.3
EV / EBITDA
EV / sales
14.4
FCF yield
4.22%
Earnings yield vs 10-yr
-0.43pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
63.3%
EBITDA margin
ROE
16.2%
ROIC
18.2%
Revenue growth
5.1%

Insider activity, last 90 days

Net open-market
$0.08m
Buyers
1
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Basic earnings per common share is computed by dividing the net income attributable to common shareholders by the weighted average number of common shares outstanding during the period. Net income attributable to common shareholders is reduced for preferred stock dividends earned during the period. The CODM evaluates current period consolidated net income performance as compared to prior periods, budgeted results and forecasts. In the second quarter of 2026, interest rate contract volume was lower compared with the same period in 2025 due to a decrease in market volatility. …CME GROUP INC., 10-Q, period ended 2026-06-30, filed 2026-07-24

Read the full passage →